{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:15:13Z","timestamp":1726762513237},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. &amp; Tumor Pharmacother."],"published-print":{"date-parts":[[1985,6]]},"DOI":"10.1007\/bf02934853","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"source":"Crossref","is-referenced-by-count":3,"title":["Treatment of dysmyelopoietic\/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside"],"prefix":"10.1007","volume":"2","author":[{"given":"H. D.","family":"Preisler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Barcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02934853_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2141.1979.tb01164.x","volume":"42","author":"V Clough","year":"1979","unstructured":"Clough V: Myelofibrosis in chronic granulocytic leukemia.Br J Haemat\n                           42, 515 (1979).","journal-title":"Br J Haemat"},{"key":"BF02934853_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198301063080105","volume":"308","author":"H D Preisler","year":"1983","unstructured":"Preisler, H D, Early, A P, Raza, A.et al: Therapy for secondary acute nonlymphocytic leukemia with cytosine arabinoside.New Engl J Med\n                           308, 21 (1983).","journal-title":"New Engl J Med"},{"key":"BF02934853_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ajcp\/67.6.512","volume":"67","author":"T Bird","year":"1977","unstructured":"Bird T and Proctor S J: Malignant myelosclerosis. Myeloproliferative disorder of leukemia?Am J Clin Pathol\n                           67, 512 (1977).","journal-title":"Am J Clin Pathol"},{"key":"BF02934853_CR4","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/bmj.2.6046.1232","volume":"2","author":"A R Patel","year":"1976","unstructured":"Patel A R, Shoh P C and Rhee H I: Acute myelofibrosis and acute myeloblastic leukemia.Br Med J\n                           2, 1232 (1976).","journal-title":"Br Med J"},{"key":"BF02934853_CR5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1445-5994.1977.tb02322.x","volume":"7","author":"A Manoharan","year":"1977","unstructured":"Manoharan A and Pitney W R: Acute myeloblastic leukemia with marrow fibrosis (malignant myelosclerosis): acute leukemia or malignant myelosclerosis?Aust NZ J Med\n                           7, 638 (1977).","journal-title":"Aust NZ J Med"},{"key":"BF02934853_CR6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V51.1.45.45","volume":"51","author":"J Breton-Gorius","year":"1978","unstructured":"Breton-Gorius J, Reyes F, Duhamel G.et al: Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase.Blood\n                           51, 45 (1978).","journal-title":"Blood"},{"key":"BF02934853_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2141.1979.tb03693.x","volume":"42","author":"G J den Ottolander","year":"1979","unstructured":"den Ottolander G J, te Velde J, Brederoo P.et al: Megakaryoblastic leukemia (acute myelofibrosis): a report of three cases.Br J Haemat\n                           42, 9 (1979).","journal-title":"Br J Haemat"},{"key":"BF02934853_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2141.1981.tb07191.x","volume":"49","author":"C Sultan","year":"1981","unstructured":"Sultan C, Sigaux F, Imbert M and Reyes F: Acute myelodysplasia with myelofibrosis: a report of eight cases.Br J Haemat\n                           49, 11 (1981).","journal-title":"Br J Haemat"},{"key":"BF02934853_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.1982.tb07299.x","volume":"51","author":"D Bevan","year":"1982","unstructured":"Bevan D, Rose M and Greaves M: Leukemia of platelet precursors: diverse features in four cases.Br J Haemat\n                           51, 147 (1982).","journal-title":"Br J Haemat"},{"key":"BF02934853_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM197807132990204","volume":"299","author":"P J Quesenberry","year":"1978","unstructured":"Quesenberry P J, Rappeport J M, Fountebuoni A,et al: Inhibition of normal hematopoiesis by leukemic cells.New Engl J Med\n                           299, 71 (1978).","journal-title":"New Engl J Med"},{"key":"BF02934853_CR11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM197908163010702","volume":"301","author":"H E Broxmeyer","year":"1979","unstructured":"Broxmeyer H E, Grossbard E, Jacoben N and Moore M A S: Persistence of inhibitory activity against normal bone marrow cells during remission of acute leukemia.New Engl J Med\n                           301, 346 (1979).","journal-title":"New Engl J Med"},{"key":"BF02934853_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V62.1.92.92","volume":"62","author":"W C Chan","year":"1983","unstructured":"Chan W C, Brynes R K, Kim T H,et al: Acute megakaryoblastic leukemia in early childhood.Blood\n                           62, 92 (1983).","journal-title":"Blood"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02934853\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:59:43Z","timestamp":1631905183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02934853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,6]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,6]]}},"alternative-id":["BF02934853"],"URL":"https:\/\/doi.org\/10.1007\/bf02934853","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1985,6]]},"article-number":"87"}}